Abstract
We report a case of Serratia marcescens meningitis that was unresponsive to therapy with ticarcillin plus systemic and intrathecal amikacin. The administration of moxalactam, 12 g/day intravenously, for 4 weeks resulted in eradication of the infection without sequelae. We were able to document therapeutic levels of moxalactam in the cerebrospinal fluid (CSF), and adequate CSF bactericidal activity was obtained. Moxalactam and other third generation cephalosporins may be valuable agents in the management of gram-negative bacillary meningitis. (Neurosurgery 10:762-765, 1982)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
